Gene expression levels of FoxP3, CTLA4, and GITR were significantly higher in both unstimulated and PHA-stimulated PBMCs from BC patients compared to healthy controls, indicating heightened Treg cell activity that may contribute to tumor progression by suppressing anti-tumor immune responses [290]. The gene discussed is CTLA4; the disease is breast cancer.